Overview

Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma

Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
The study aim is to investigate if changes in osmolarity using mannitol challenge can evoke coughing reproducibly in mild allergic asthmatics compared with healthy controls and if salbutamol can affect this. Phase 1 of this study is a reproducibility analysis of cough dose response to mannitol in a cohort of mild allergic asthmatics and healthy controls. Phase 2 is a double-blind, placebo-controlled analysis in mild allergic asthmatics assessing the effects of salbutamol on mannitol induced cough.
Phase:
N/A
Details
Lead Sponsor:
McMaster University
Collaborators:
AllerGen NCE Inc.
Pharmaxis
Treatments:
Albuterol
Mannitol